Full-Time

Rare Disease Manager

Multiple Positions

Confirmed live in the last 24 hours

SpringWorks Therapeutics

SpringWorks Therapeutics

201-500 employees

Develops precision medicines for rare diseases

No salary listed

Senior

Remote in Germany

Candidate must live within the identified territory within country level.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s Degree in a scientific field required; advanced degree preferred.
  • 7+ years of related experience
  • 5+ years proven Rare Disease sales experience and business acumen in the pharmaceutical/ healthcare industry with demonstration of successful results
  • Drug product launch experience in previously unchartered territory; proven entrepreneurial track record and mindset
  • Experience in oncology and strong scientific/medical knowledge preferred
  • Experience in rare disease field or in-hospital specialty care business including referral networks. Experience in engaging with Centers of Excellence and/or Key Accounts
  • Strong business acumen and proficient use of business tools; possesses strategic and critical thinking capabilities
  • In-depth scientific, therapeutic, product, and competitive knowledge and recognition as an expert resource by all relevant stakeholders.
  • Relevant drug launch experience in highly specialized care setting
  • Excellent selling skills: ability to proactively identify customer’s style / behavior and adapt quickly with all aspects of selling approach
  • Analytical thinking and ability to create business plans
  • Resilient and value-driven; eager to achieve mid/term-goals in addition to the short-term objectives.
  • Team player understands the value of collaboration across the organization and the importance of sharing knowledge and best practice
  • Possesses high integrity and exceptional work ethic. Fosters mutual trust and respect
  • Speaks German (mother tongue), English (fluent in reading and understanding of scientific data and documentation, as well as internal exchange in an international team).
  • Strong interpersonal communication skills to collaborate with colleagues, stakeholders, and vendors effectively and clearly in a remote hybrid work environment.
  • Ability to travel occasionally including overnight stay driven by business need.
Responsibilities
  • Achieve short and long-term sales objectives by building trusted customer relationships, based on understanding customer needs and providing solutions to create a professional relationship between the customer and SpringWorks in both the live and virtual setting, as well as, within the community/academic setting respectfully
  • Accountable for overall territory revenue and customer support
  • Create, lead, execute and regularly update a strategic territory plan, reflecting on product strategies and tactics, market insights, competitor landscape, customer needs of defined account target groups and the specific patient journey to optimize patient access to medicine whilst driving product sales and business plan objectives against target
  • Drive disease awareness and support patient finding alongside the entire patient journey to reduce time to diagnosis for patients by mapping and supporting referral pathways from non-expert centers to expert centers
  • Develop and execute strategic account plans – covering all critical roles of each account’s ecosystem - that achieve qualitative and quantitative account objectives and optimizes coverage and frequency to key customers to maximize access and sales opportunities
  • Maintain an expert operating knowledge of all company policies and guidelines including but not limited to those addressing interactions with Healthcare Professionals, compliance and business conduct.
  • Effectively share the product value proposition, handle objections and consistently gain logical and reasonable calls to action to close on every sales call.
  • Establish and maintain an exceptional knowledge of the customers, the related market, the science and the disease state’s therapeutic approaches and the broader healthcare space.
  • Continuously collaborate by sharing market intelligence information with in-field team, brand team and first line manager to anticipate environmental changes and to optimize brand strategy, account plans and its execution. Leverage different tools and communication channels – i.e. CRM, dashboards, market data and omnichannel platforms – to continuously shape the strategic development and the implementation of the tactical activities. Act as the ‘voice of the customer’ for the internal team to create value-adding materials and services
  • Act as the ‘voice of the customer’ for the internal team to create value-adding materials and services
  • Support activities to get consents and opt-ins.
  • Actively participate and represent client on scientific congresses based on ethical and compliant behavior.
  • Perform other duties and responsibilities as assigned.
Desired Qualifications
  • Experience in oncology and strong scientific/medical knowledge preferred
  • Experience in rare disease field or in-hospital specialty care business including referral networks. Experience in engaging with Centers of Excellence and/or Key Accounts
SpringWorks Therapeutics

SpringWorks Therapeutics

View

SpringWorks Therapeutics develops and commercializes precision medicines aimed at treating rare diseases and cancer. Their approach focuses on tailoring treatments to the genetic and molecular characteristics of diseases, which helps enhance the effectiveness and safety of their therapies for patients who often have limited options. The company operates within the biopharmaceutical sector, acquiring and developing innovative therapies, and collaborates with other pharmaceutical firms to bring these treatments to market. SpringWorks targets a specific group of patients with unique genetic profiles, providing them with potentially life-changing therapies that are not commonly available. They are actively conducting clinical trials, including Phase 1b and 2 studies, to assess the safety and effectiveness of their drug candidates.

Company Size

201-500

Company Stage

IPO

Headquarters

New York City, New York

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Merck's acquisition enhances SpringWorks' resources for cancer drug development.
  • AI-driven drug discovery aligns with SpringWorks' precision medicine approach.
  • Increased investment in rare disease research offers partnership opportunities.

What critics are saying

  • Integration challenges post-acquisition could disrupt clinical trials.
  • Potential loss of key talent may impact innovation and efficiency.
  • Regulatory scrutiny could delay the acquisition's finalization.

What makes SpringWorks Therapeutics unique

  • SpringWorks focuses on precision medicine for rare diseases and cancer.
  • The company tailors treatments based on genetic and molecular disease profiles.
  • SpringWorks targets underserved patient populations with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Sick Leave

Professional Development Budget

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

0%

2 year growth

1%
Merck Group
May 5th, 2025
agreement-to-acquire-springworks

Merck KGaA, Darmstadt, Germany, and SpringWorks Therapeutics, have entered into a definitive agreement for us to acquire SpringWorks.

MedCity News
Apr 28th, 2025
Merck KGaA's Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition

When SpringWorks went public in 2019, the biotech priced its shares at $18 each.

ITjuzi
Apr 28th, 2025
Merck Acquires SpringWorks for $3.9B

German Merck Group has announced a $3.9 billion acquisition agreement with U.S. biopharmaceutical company SpringWorks Therapeutics. This acquisition aims to enhance Merck's cancer drug business. SpringWorks Therapeutics, a biopharmaceutical developer, has obtained four potential new drugs in clinical stages from Pfizer.

Dunya
Apr 28th, 2025
Merck acquires SpringWorks for $3.9B

Merck announced it will acquire SpringWorks Therapeutics for approximately $3.9 billion, with a purchase offer of $47 per share, which is 26% above the average price before February 2025 market speculations. The acquisition aims to expand Merck's sales in the cancer treatment sector. The deal involves a cash payment to SpringWorks Therapeutics, based in Connecticut, USA.

36Kr
Apr 28th, 2025
Merck Acquires SpringWorks for $3.9B

Merck KGaA, a German healthcare and materials group, announced an agreement to acquire U.S. biotechnology company SpringWorks Therapeutics for an equity value of $3.9 billion. The acquisition aims to strengthen Merck's cancer drug business. The cash purchase price is $47 per share, representing an enterprise value of $3.4 billion (€3 billion) after deducting SpringWorks' cash holdings. The companies recently concluded negotiations on the $47 per share offer.